Cargando…
Tacrolimus Inhibits the Revascularization of Isolated Pancreatic Islets
AIMS: Immunosuppressive drugs could be crucial factors for a poor outcome after islet allotransplantation. Unlike rapamycin, the effects of tacrolimus, the current standard immunosuppressant used in islet transplantation, on graft revascularization remain unclear. We examined the effects of tacrolim...
Autores principales: | Nishimura, Ryuichi, Nishioka, Sho, Fujisawa, Ikuma, Shiku, Hitoshi, Shimada, Miki, Sekiguchi, Satoshi, Fujimori, Keisei, Ushiyama, Akira, Matsue, Tomokazu, Ohuchi, Noriaki, Satomi, Susumu, Goto, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629082/ https://www.ncbi.nlm.nih.gov/pubmed/23613708 http://dx.doi.org/10.1371/journal.pone.0056799 |
Ejemplares similares
-
Thioredoxin-1 Attenuates Early Graft Loss after Intraportal Islet Transplantation in Mice
por: Asami, Kengo, et al.
Publicado: (2013) -
Ductal Injection Does Not Increase the Islet Yield or Function after Cold Storage in a Vascular Perfusion Model
por: Nakanishi, Wataru, et al.
Publicado: (2012) -
KRP-203 Is a Desirable Immunomodulator for Islet Allotransplantation
por: Fathi, Ibrahim, et al.
Publicado: (2021) -
Donor Islet Endothelial Cells in Pancreatic Islet Revascularization
por: Nyqvist, Daniel, et al.
Publicado: (2011) -
Electrochemical Hydrogel Lithography of Calcium-Alginate Hydrogels for Cell Culture
por: Ozawa, Fumisato, et al.
Publicado: (2016)